13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q2 2016. See the latest, Q2 2026 →
Reported value
$23.54B
+3.6% on the quarter before
Positions
55
13 new · 21 sold out
Top 10
54.9%
of the value
Est. gain
+$569.5M
on stocks held all quarter
Est. return
+3.2%
on those stocks since Q1 2016
Positions as of Jun 30, 2016, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.
Largest buys
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Biogen Inc~$720.5MAdded · 0.3% → 3.3%+2,979,560 shares
- T Mobile Us Inc~$488.3MAdded · 0.5% → 2.6%+11,285,490 shares
- Mastercard~$394.5MAdded · 0.8% → 2.4%+4,479,636 shares
- Anadarko Pete Corp~$370.1MAdded · 0.2% → 1.8%+6,949,514 shares
- Intercontinental Exchange In~$290.1MNew · 0.0% → 1.2%+1,133,502 shares
- Microsoft~$288.3MNew · 0.0% → 1.2%+5,633,782 shares
- Rice Energy Inc~$278.0MNew · 0.0% → 1.2%+12,613,321 shares
- Newell Brands Inc~$252.8MAdded · 0.9% → 2.1%+5,205,834 shares
- Davita Healthcare Partners I~$221.7MAdded · 0.6% → 1.5%+2,867,210 shares
- Alibaba~$209.6MAdded · 0.5% → 1.4%+2,635,329 shares
Largest sells
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Allergan Plc~$679.9MCut · 5.8% → 1.9%−2,942,254 shares
- Anthem Inc~$674.0MSold out · 3.0% → 0.0%−4,849,229 shares
- Aetna Inc New~$353.7MCut · 1.9% → 0.5%−2,896,103 shares
- Teva Pharmaceutical Inds Ltd~$263.0MCut · 7.8% → 5.9%−5,234,967 shares
- Transdigm Group Inc~$242.7MSold out · 1.1% → 0.0%−1,101,310 shares
- Walgreens Boots Alliance Inc~$233.9MCut · 2.3% → 1.2%−2,809,472 shares
- Eli Lilly~$187.9MCut · 3.7% → 3.1%−2,386,383 shares
- Alphabet~$179.8MCut · 6.9% → 5.4%−255,560 shares
- Pioneer Nat Res Co~$179.4MCut · 1.6% → 0.9%−1,186,582 shares
- Canadian Pac Ry Ltd~$174.0MCut · 1.3% → 0.5%−1,351,042 shares
Holdings
As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AmazonCOM · shares −4.6% · price +20.5% | 10.0% | $2.35B | +$400.0M | ||||||||
| MetaCL A · shares +0.06% · price +0.2% | 9.8% | $2.30B | +$3.6M | ||||||||
| Broadcom LtdSHS · shares +3.9% · price +0.6% | 6.7% | $1.59B | +$8.8M | ||||||||
| Teva Pharmaceutical Inds LtdADR · shares −16% · price −6.1% | 5.9% | $1.39B | −$91.0M | ||||||||
| AlphabetCAP STK CL A · shares −12% · price −7.8% | 5.4% | $1.26B | −$106.6M | ||||||||
| Air Prods & Chems IncCOM · shares +0.5% · price −1.4% | 4.2% | $986.4M | −$13.9M | ||||||||
| Cabot Oil & Gas CorpCOM · shares −3.0% · price +13.3% | 3.9% | $909.3M | +$107.0M | ||||||||
| Biogen IncCOM · shares +1,290% · price −7.1% | 3.3% | $776.4M | −$4.3M | ||||||||
| Eli LillyCOM · shares −20% · price +9.4% | 3.1% | $738.5M | +$63.2M | ||||||||
| Encana CorpCOM · shares 0% · price +27.9% | 2.7% | $627.7M | +$137.0M | ||||||||
| T Mobile Us IncCOM · shares +421% · price +13.0% | 2.6% | $604.3M | +$13.3M | ||||||||
| AlphabetCAP STK CL C · shares −20% · price −7.1% | 2.5% | $582.2M | −$44.5M | ||||||||
| NetflixCOM · shares −22% · price −10.5% | 2.4% | $575.3M | −$67.6M | ||||||||
| MastercardCL A · shares +229% · price −6.8% | 2.4% | $566.4M | −$12.6M | ||||||||
| Newell Brands IncCOM · shares +110% · price +9.7% | 2.1% | $482.6M | +$20.2M | ||||||||
| Jd Com IncSPON ADR CL A · shares +49% · price −19.9% | 2.0% | $477.6M | −$79.5M | ||||||||
| Southwestern Energy CoCOM · shares 0% · price +55.9% | 2.0% | $473.8M | +$169.9M | ||||||||
| Allergan PlcSHS · shares −60% · price −13.8% | 1.9% | $448.2M | −$71.7M | ||||||||
| Anadarko Pete CorpCOM · shares +814% · price +14.3% | 1.8% | $415.5M | +$5.7M | ||||||||
| Range Res CorpCOM · shares +5.3% · price +33.2% | 1.7% | $402.7M | +$95.4M | ||||||||
| Davita Healthcare Partners ICOM · shares +164% · price +5.4% | 1.5% | $356.6M | +$6.9M | ||||||||
| AlibabaSPONSORED ADS · shares +189% · price +0.6% | 1.4% | $320.6M | +$697,405 | ||||||||
| Calpine CorpCOM NEW · shares +94% · price −2.8% | 1.3% | $300.4M | −$4.4M | ||||||||
| Intercontinental Exchange InCOM · shares New | 1.2% | $290.1M | — | ||||||||
| Walgreens Boots Alliance IncCOM · shares −45% · price −1.2% | 1.2% | $288.9M | −$3.4M | ||||||||
| Total · 55 positions | 100% | $23.54B | +$569.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2016 to Q2 2016: 42 stocks held throughout, up $569.5M (+3.2%).
- Amazon+$400.0M+21%
- Southwestern Energy Co+$169.9M+56%
- Encana Corp+$137.0M+28%
- Cabot Oil & Gas Corp+$107.0M+13%
- Range Res Corp+$95.4M+33%
- Netflix−$67.6M−11%
- Allergan Plc−$71.7M−14%
- Jd Com Inc−$79.5M−20%
- Teva Pharmaceutical Inds Ltd−$91.0M−6%
- Alphabet−$106.6M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |